Holen Sie sich die Stockscreener-App
7.36
2.00%
-0.15
Vorhandelsmarkt:
7.46
0.10
+1.36%
Schlusskurs vom Vortag:
$7.51
Offen:
$7.46
24-Stunden-Volumen:
361.21K
Relative Volume:
0.23
Marktkapitalisierung:
$228.17M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-29.25M
KGV:
-6.2057
EPS:
-1.186
Netto-Cashflow:
$-22.80M
1W Leistung:
+4.10%
1M Leistung:
-10.79%
6M Leistung:
+98.12%
1J Leistung:
+138.96%
1-Tages-Spanne:
$7.131
$7.675
1-Wochen-Bereich:
$7.07
$7.86
52-Wochen-Spanne:
$1.73
$11.41
Sagimet Biosciences Inc Stock (SGMT) Company Profile
Firmenname
Sagimet Biosciences Inc
Sektor
Branche
Telefon
(650) 561-8600
Adresse
155 BOVET RD., SUITE 303, SAN MATEO
Vergleichen Sie SGMT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
7.36 | 244.24M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-11 | Eingeleitet | Wedbush | Outperform |
| 2025-08-07 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-07-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-12-06 | Eingeleitet | Oppenheimer | Outperform |
| 2024-11-12 | Eingeleitet | UBS | Buy |
| 2024-06-28 | Herabstufung | Goldman | Buy → Neutral |
| 2024-05-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-03-25 | Eingeleitet | Leerink Partners | Outperform |
| 2023-08-08 | Eingeleitet | Goldman | Buy |
| 2023-08-08 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-08-08 | Eingeleitet | Piper Sandler | Overweight |
| 2023-08-08 | Eingeleitet | TD Cowen | Outperform |
Alle ansehen
Sagimet Biosciences Inc Aktie (SGMT) Neueste Nachrichten
Is Sagimet Biosciences Inc. gaining market shareTrend Reversal & Free High Accuracy Swing Entry Alerts - خودرو بانک
Applying sector rotation models to Sagimet Biosciences Inc.July 2025 WrapUp & Advanced Swing Trade Entry Plans - Newser
How high can Sagimet Biosciences Inc. stock go2025 Market Overview & Daily Risk Controlled Trade Plans - Newser
Is Sagimet Biosciences Inc. stock a buy or sellMarket Risk Analysis & Reliable Price Breakout Alerts - خودرو بانک
Can Sagimet Biosciences Inc. deliver consistent dividendsJuly 2025 Market Mood & Reliable Intraday Trade Plans - خودرو بانک
Is Sagimet Biosciences Inc. meeting your algorithmic filter criteriaLong Setup & Real-Time Chart Breakout Alerts - Newser
Earnings visualization tools for Sagimet Biosciences Inc.Options Play & Safe Capital Investment Plans - Newser
How to build a dashboard for Sagimet Biosciences Inc. stockMarket Sentiment Report & Technical Pattern Alert System - Newser
Can volume confirm reversal in Sagimet Biosciences Inc.Forecast Cut & High Accuracy Trade Alerts - Newser
Is Sagimet Biosciences Inc. stock a good pick for beginnersJuly 2025 Analyst Calls & Real-Time Volume Analysis Alerts - خودرو بانک
Real time social sentiment graph for Sagimet Biosciences Inc.2025 Breakouts & Breakdowns & AI Powered Market Entry Strategies - Newser
Sagimet Biosciences Inc. stock momentum explained2025 Investor Takeaways & Free Fast Entry Momentum Trade Alerts - Newser
Is Sagimet Biosciences Inc. stock bottoming outWatch List & Daily Market Momentum Tracking - Newser
How high can Sagimet Biosciences Inc. stock price go in 2025Bear Alert & Low Drawdown Momentum Trade Ideas - Newser
How to monitor Sagimet Biosciences Inc. with trend dashboards2025 Volume Leaders & Long-Term Growth Stock Strategies - Newser
Sagimet Biosciences Inc.’s volatility index tracking explainedTreasury Yields & AI Forecasted Stock Moves - Newser
Using data filters to optimize entry into Sagimet Biosciences Inc.Quarterly Growth Report & Free Safe Capital Growth Stock Tips - Newser
Tools to monitor Sagimet Biosciences Inc. recovery probabilityWeekly Trade Report & Community Consensus Picks - Newser
Momentum Screeners Rank Sagimet Biosciences Inc. in Top 5 TodayJuly 2025 Pullbacks & Advanced Technical Analysis Signals - beatles.ru
Sagimet Biosciences: Strong Pipeline Progress, Funding Overhang Keeps Stock at Hold - AInvest
Sagimet Biosciences: Strong Denifanstat Pipeline Progress, Funding Overhang Keeps Stock At Hold - Seeking Alpha
Sagimet Biosciences Inc. recovery potential after sell offJuly 2025 Sector Moves & Weekly Market Pulse Updates - Newser
How to use a screener to detect Sagimet Biosciences Inc. breakoutsLong Setup & AI Enhanced Market Trend Forecasts - Newser
Is Sagimet Biosciences Inc. building a consolidation baseWeekly Profit Recap & Fast Moving Stock Trade Plans - Newser
Sector ETF performance correlation with Sagimet Biosciences Inc.Buy Signal & Technical Pattern Based Signals - Newser
Will Sagimet Biosciences Inc. Reverse From Oversold ConditionsSwing Trade & Safe Entry Zone Identification - beatles.ru
Custom watchlist performance reports with Sagimet Biosciences Inc.2025 Short Interest & Real-Time Chart Pattern Alerts - Newser
Is Sagimet Biosciences Inc. still worth holding after the dipJuly 2025 Intraday Action & Daily Entry Point Alerts - Newser
Finanzdaten der Sagimet Biosciences Inc-Aktie (SGMT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sagimet Biosciences Inc-Aktie (SGMT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Martins Eduardo Bruno | Chief Medical Officer |
Jul 21 '25 |
Sale |
9.13 |
8,277 |
75,607 |
106,936 |
| Rozek Elizabeth | General Counsel and CCO |
Jul 21 '25 |
Sale |
9.13 |
10,780 |
98,471 |
183,726 |
4.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):